Aventis 2002.
Trial name or title | An open‐label, randomised, parallel group, multicentre study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism in people following acute ischaemic stroke |
Methods | |
Participants | |
Interventions | |
Outcomes | |
Starting date | |
Contact information | Ms S Wellington, Senior Clinical Project Leader, Aventis Pharma, Aventis House, 50 Kings Hill Avenue, Kings Hill, West Malling, Kent, UK |
Notes |